Delivery Order 36C24921D0022-36C24923N0177

Award Date 1/19/23
Potential Completion Date 1/18/24
Potential Value $68K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Castleton, IN 46256, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Veterans Affairs (VA) awarded a $132,686.76 firm-fixed-price delivery order to Roche Diagnostics Corporation, a foreign-owned for-profit manufacturer of in vitro diagnostics, reagents, and laboratory equipment. The contract, which was not set aside, was issued under the VA's Veterans Integrated Service Network 12 and will provide molecular pathology services to support the VA's COVID-19 response efforts. Roche Diagnostics has a history of supplying critical medical equipment,...
Roche Diagnostics Corporation was awarded a $139,272 firm fixed price delivery order for influenza A/B and COVID testing by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 9. The contract has a period of performance through January 25, 2022 to provide testing services for VA medical facilities located in Castleton, Indiana. As part of the VA's response to the Coronavirus COVID-19 pandemic, this delivery order will support continued testing...
Roche Diagnostics Corporation was awarded a $111,133.14 firm fixed price delivery order for Option Year 1 of influenza A/B and COVID testing services. The contract has no set-aside designation and is being carried out by Roche for the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 9. Performance will take place in Castleton, Indiana through January 18, 2026. This delivery order is likely issued against an existing...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 8 awarded a $1.12 million delivery order contract to Roche Diagnostics Corporation for the provision of molecular testing services. Specifically, Roche will provide cost per test for molecular testing to support the VA's response to the novel coronavirus pandemic. The firm fixed price contract runs from October 1, 2020 through January 31, 2022 and will be performed in Castleton, Indiana. No...
The Department of Veterans Affairs (VA) Veterans Health Administration awarded a $350,000 firm-fixed-price purchase order to Roche Diagnostics Corporation for the purchase of laboratory equipment capable of COVID-19 testing. The contract, which had a completion date of May 19, 2021, was not set aside for any socioeconomic program. Roche Diagnostics Corporation, a foreign-owned for-profit manufacturer of in vitro diagnostics, reagents, and laboratory instruments, has provided critical medical...
This is a firm fixed-price delivery order awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp. The $119,412.00 contract is for COVID-19 molecular testing services. Roche Diagnostics is a foreign-owned, for-profit manufacturer that has received numerous federal contract awards from agencies including the VA, Department of Defense, and Department of Health and Human Services to provide...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 17 (VA - VHA) awarded Roche Diagnostics Corporation a $298,741.50 purchase order contract to provide Emergency COVID Testing services. The contract has a start date of May 3, 2023 and an end date of December 30, 2023. Performance will take place in Castleton, Indiana and the pricing is firm fixed price. As Roche Diagnostics Corporation is a leading provider of diagnostic solutions, it is...
Roche Diagnostics Corporation has been awarded an $886,325 fixed-price purchase order by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 17 to provide COVID-19 reagents and consumables. Under this contract, Roche will supply test kits, reagents, and related materials to support the VA's coronavirus diagnostic testing efforts through December 2021. The contract was awarded using Coronavirus COVID-19 national interest funding to address the...
The Department of Veterans Affairs Veterans Health Administration awarded a firm fixed price purchase order to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, for the delivery of COBAS SAR-COV2 Test Kits. The contract, valued at $296,933.70, was awarded on April 2, 2020 with a completion date of August 2, 2020. The contract does not have a set-aside designation and is part of the federal government's response to the Coronavirus COVID-19 National Interest Action. Roche...
The Department of Veterans Affairs (VA) awarded a $136,091.62 firm-fixed-price delivery order to Roche Diagnostics Corporation, a foreign-owned for-profit manufacturer of in vitro diagnostic products, for the procurement of medical testing kits. The award was made under Roche's existing General Services Administration (GSA) Schedule Contract for critical laboratory analyzers and supplies (FSS-66-III). This delivery order does not have a set-aside designation. Roche has a history of providing a...
  • 36C24921D0022
    Indefinite Delivery Contract
  • 36C24921D0022-36C24923N0177
    Delivery Order

The Department of Veterans Affairs Veterans Health Administration has awarded a firm fixed-price delivery order to Roche Diagnostics Corporation, a foreign-owned for-profit manufacturer, to provide influenza A/B and COVID-19 testing supplies and services. The one-year order, valued at $67,881.98, supports the Veterans Integrated Service Network 9 in Castleton, Indiana. Roche Diagnostics, which holds multiple General Services Administration schedule contracts and other Indefinite Delivery Vehicles with federal agencies, has previously provided medical equipment, reagents, and laboratory services to the VA, Department of Defense, and other government customers. This order does not have a set-aside designation. The contract leverages Roche's established pricing and terms to streamline the VA's procurement of these critical diagnostic testing capabilities.

Generated 3/30/24, 11:48 AM